Recent News

• 05.08.2025 - Catalyst Pharmaceuticals First Quarter 2025 Financial Results
• 05.08.2025 - Catalyst Pharmaceuticals First Quarter 2025 Financial Results
• 04.22.2025 - Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
• 04.22.2025 - Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
• 04.22.2025 - Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
• 04.08.2025 - Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
• 04.08.2025 - Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
• 04.08.2025 - Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
• 03.11.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.11.2025 - Barclays 27th Annual Global Healthcare Conference

Recent Filings

• 04.14.2025 - ARS Annual Report to Security Holders
• 04.11.2025 - DEF 14A Other definitive proxy statements
• 04.09.2025 - 8-K Current report
• 04.09.2025 - EX-99.1 EX-99.1
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 144 Report of proposed sale of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 144 Report of proposed sale of securities